(Reuters) -Blackstone and TPG have agreed to amass medical diagnostics agency Hologic in an as much as $18.3 billion deal, it stated on Tuesday, marking one of many largest healthcare take-private transactions this 12 months.
Below the settlement, Blackstone and TPG can pay $76 apiece in money to amass all excellent Hologic shares, implying a premium of almost 6% to inventory’s final closing value.
Shareholders are additionally eligible for a non-tradable proper to obtain as much as $3 per share, contingent on sure international income targets for its breast well being enterprise in fiscal years 2026 and 2027, bringing the overall potential payout to $79 per share.
Hologic shares have been up greater than 4% in premarket buying and selling, after being briefly halted.
The corporate focuses on girls’s well being diagnostics, together with breast and cervical most cancers screening and infectious illness testing.
It has seen regular progress in molecular diagnostics enterprise and reported upbeat monetary outcomes, however flagged continued weak point within the breast well being section.
The deal is predicted to shut within the first half of 2026.
(Reporting by Padmanabhan Ananthan, Sneha S Ok and Mariam Sunny in Bengaluru; Enhancing by Shilpi Majumdar)